Anthony Gulati, MD
Hematology Oncology PC
Stamford, CT 06904
Main: 203.276.2695
Fax: 203.975.7842
About Me
Dr. Gulati believes in a personal touch with his patients, striving to develop open communication and always remain accessible. He enjoys working with his patients to solve difficult treatment problems and offers personalized care to fit his patients’ needs.
After receiving his specialized fellowship training at Columbia University, Dr. Gulati chose to focus on treating patients with genitourinary, gastrointestinal, and neuroendocrine cancers. In 2015, Dr. Gulati was awarded the Rookie of the Year award in the Department of Medicine at Stamford Health for quality patient care during his first year of service. Dr. Gulati helps shape the future of oncology through clinical research and by serving as a clinical professor of medicine at Columbia University. He uses the latest treatments, including immunotherapy and clinical trials, to help his patients fight cancer.
-
Specialties
Specialties
Hematology
Internal Medicine
Medical OncologySpecial Interests
Bladder cancer
Gastrointestinal cancers
Genital urinary cancers
Hematologic disorders and malignancies
Kidney cancer
Lung Cancer
Neuroendocrine cancers
Prostate cancer
Testicular cancerLanguages
English
-
Education & Training
Medical School
Perelman School Of Medicine At The University Of Pennsylvania
Residency
Hospital of the University of Pennsylvania
Fellowship
New York-Presbyterian Hospital
-
Board Certifications & Affiliations
Board Certifications
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Internal Medicine
American Board of Internal Medicine - Medical OncologyAffiliations
American Society of Clinical Oncology
Published Work
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series
Zacharia BE, Gulati AP, Bruce JN, Carminucci AS, Wardlaw SL, Siegelin M, Remotti H, Lignelli A, Fine RL. Neurosurgery. 2014 Apr;74(4):E447-55; discussion E455. doi: 10.1227/NEU.0000000000000251.
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
Fine RL, Gulati AP, Krantz BA, Moss RA, Schreibman S, Tsushima DA, Mowatt KB, Dinnen RD, Mao Y, Stevens PD, Schrope B, Allendorf J, Lee JA, Sherman WH, Chabot JA. Cancer Chemother. Pharmacol. 2013 Mar;71(3):663-70. doi: 10.1007/s00280-012-2055-z. Epub 2013 Jan 31.
Treatment of multiple endocrine neoplasia 1/2 tumors: case report and review of the literature
Gulati AP, Krantz B, Moss RA, Moyal WN, Tsushima DA, Mowatt KB, Schreibman S, Fine RL. Oncology. 2013;84(3):127-34. doi: 10.1159/000342961. Epub 2012 Dec 8.
Is there a role for liver transplantation in metastatic pancreatic neuroendocrine tumors (PNET)?
Gulati AP, Saif MW. JOP. 2012 May 10;13(3):320-1.
Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
Gulati AP, Saif MW. Anticancer Res. 2012 Apr;32(4):1375-7.
The clinical management of BRCA1 and BRCA2 mutation carriers.
Gulati AP, Domchek SM. Curr. Oncol Rep. 2008 Jan;10(1):47-53.
Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1
Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M. Mol Carcinog. 2006 Jan;45(1):26-37. Erratum in: Mol Carcinog. 2006. Jul;45(7):549.
If You Are in Need of Emergency Care, Call 911.
The majority of the physicians on the Stamford Hospital Medical Staff are not employees or agents of the Hospital. They are independent practitioners who have been granted the privilege of using the Hospital's facilities for the care and treatment of their patients. This includes, but is not limited to, emergency department physicians, anesthesiologists, radiologists, surgeons, cardiologists, obstetricians, pathologists and other consultants who may treat patients.
Insurance listings are subject to change at any time. Please verify insurance plan acceptance when scheduling an appointment with a healthcare provider.